Physician profile
Christopher Trower
NPI 1477182343
$6,260.16
in general payments reported to CMS, 2019-2025
17 companies · $1,642 in 2025
The $1,642 reported for 2025 was more than what 92% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $57.74 · 2023: $255 · 2024: $4,305 · 2025: $1,642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,512 · Travel and Lodging: $2,061 · Education: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,511.66 |
| Travel and Lodging | $2,061.40 |
| Education | $629.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,884.69 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $837.61 | 2024 | Senza |
| Merz Pharmaceuticals, LLC | $437.88 | 2024 | Xeomin |
| Abbott Laboratories | $331.37 | 2025 | Eterna |
| Globus Medical, INC. | $298.68 | 2025 | Senza |
| Saluda Medical Americas, INC. | $244.05 | 2025 | Evoke |
| Boston Scientific Corporation | $221.07 | 2024 | Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $183.83 | 2025 | Sprint Pns System |
| Ipsen Biopharmaceuticals, INC | $166.46 | 2022-2024 | Dysport |
| Forte Bio-Pharma LLC | $153.34 | 2025 | Prolate, Tanlor, Nalocet |
| Spinal Simplicity, LLC | $135.83 | 2025 | Ha Minuteman G3-R |
| Averitas Pharma INC. | $117.29 | 2023-2024 | Qutenza |
| Bioventus LLC | $115.90 | 2025 | Stimrouter Implantable Kit |
| Abbvie INC. | $44.57 | 2023 | Botox |
| Collegium Pharmaceutical, INC. | $43.69 | 2022-2023 | Xtampza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $26.57 | 2025 | Prospera |
| Allergan, INC. | $17.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Trower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.